Mayo Clinic Center for Clinical and Translational Science (CCaTS)
梅奥诊所临床和转化科学中心 (CCaTS)
基本信息
- 批准号:10632337
- 负责人:
- 金额:$ 781.85万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-18 至 2027-06-30
- 项目状态:未结题
- 来源:
- 关键词:AddressAdvocateCOVID-19COVID-19 pandemicCaringClinicClinical ResearchClinical SciencesClinical TrialsClinical and Translational Science AwardsCommunitiesCompetenceCountryEducationElementsEnvironmentEventFacultyFoundationsFundingGoalsHealthHealth systemHealthcareHumanIncubatorsIndividualInformaticsInstitutionInterdisciplinary StudyInvestmentsJusticeKnowledgeLeadershipLearningMedical StudentsMethodologyMethodsMinnesotaMissionNational Center for Advancing Translational SciencesPatient CarePatientsPersonsPopulationPositioning AttributeProcessResearchResearch PersonnelResourcesRoleRural PopulationScientistSecureStructural RacismTalentsTechnologyTrainingTraining and EducationTranslational ResearchTranslationsTrustUnited States National Institutes of HealthVisionWorkbaseclinical centerclinical practicedigitaldigital healthdiversity and equitygraduate studenthealth care service organizationhealth disparityhealth equityhealth equity promotionhealth inequalitiesimprovedinnovationinterestmedical schoolsmembermultidisciplinarynoveloperationpandemic diseaseprogramsresponsescience educationsocial disparitiessynergismtheoriestoolunderserved community
项目摘要
Contact PD/PI: Lucchinetti, Claudia F.
OVERALL: Project Summary/Abstract
Mayo Clinic is one of the largest not‐for‐profit, academic health systems, top-ranked for quality more often than
any other health care organization. It has integrated operations in 5 U.S. states, and more than 1 million people
came to Mayo Clinic for care last year. Clinical and translational science (CTS) is a fundamental and highly
valued element of Mayo Clinic; indeed, all research at Mayo Clinic is directed towards translation of scientific
knowledge to improve patient care, with almost 60% of our NIH funding base classified as clinical research or
trials. In recognition of the importance of continued advances in CTS to the Mayo Clinic mission, our
institutional leadership has entrusted the Mayo Clinic Center for Clinical and Translational Sciences (CCaTS)
to be the engine of translational innovation and the institutional advocate for CTS and translational research.
CCaTS has served as a CTS innovation incubator for numerous efforts that were created with CCaTS funding
and are now supported by the institution. The overall vision of CCaTS is to enable high-quality, team-based
multidisciplinary research that accelerates clinical trial innovation, facilitates digital health transformation, and
partners with our stakeholders and communities to improve patient care and health for all people. Our team-
based culture has been described as one of “boundarylessness,” wherein organizational barriers are removed
to enable talent, innovation, and knowledge to converge where needed. In this context and that of our
longstanding commitment to patient-focused research, we are uniquely positioned to accomplish the following
Specific Aims. In Aim 1, we will simplify and accelerate the work of translation to improve health for all by
advancing clinical trial innovations and digital health transformations, streamlining methods and processes,
and developing novel informatics solutions that increase efficiency and drive implementation of discoveries that
improve health and promote health equity. In Aim 2, we will enhance our education programs through the
expanded reach of competency-based, learner-focused solutions, training a diverse, inclusive, multidisciplinary
CTS workforce to be prepared to address the urgent health care needs of all communities in a rapidly changing
environment. In Aim 3, we will engage local community members and patients to be active partners in
translational teams, expanding research capabilities of underserved communities, including rural populations.
Our goal is to improve health and reduce health inequities by helping these communities realize the benefits of
CTS. In Aim 4, we will expand national and regional partnerships and strengthen collaborative CTS networks
in all aspects of CTS and education, focusing on sharing innovative approaches and prioritizing diversity,
equity, and inclusion, with the goal of improving human health and advancing health equity. In summary,
sustained investment in CCaTS will enable us to continue to meet ongoing and emergent challenges in health
care for all, as exemplified by our response to support communities through the COVID-19 crisis.
Project Summary/Abstract Page 289
Contact PD/PI: Lucchinetti, Claudia F.
联系PD/PI:Lucchinetti,Claudia F.
总体:项目概要/摘要
马约诊所是最大的非营利学术卫生系统之一,
其他医疗机构。它在美国5个州开展了综合业务,
去年来马约诊所接受治疗。临床和转化科学(CTS)是一个基础和高度
马约诊所的重要元素;事实上,马约诊所的所有研究都是针对科学的翻译,
知识,以改善病人护理,与我们的国家卫生研究院资金基础的近60%归类为临床研究或
审判认识到CTS持续进步对马约诊所使命的重要性,我们
机构领导层委托马约诊所临床和转化科学中心(CCaTS)
成为翻译创新的引擎,以及CTS和翻译研究的机构倡导者。
CCaTS作为CTS创新孵化器,为CCaTS资助的许多项目提供了支持
现在得到了机构的支持。CCaTS的总体愿景是实现高质量、基于团队的
多学科研究,加速临床试验创新,促进数字化健康转型,
与我们的利益相关者和社区合作,为所有人改善患者护理和健康。我们的团队-
一种基于基础的文化被描述为一种“无边界”的文化,在这种文化中,组织的障碍被消除了
使人才、创新和知识能够在需要的地方汇聚。在这种情况下,
长期致力于以患者为中心的研究,我们处于独特的地位,以实现以下目标
具体目标。在目标1中,我们将简化和加快翻译工作,以改善所有人的健康,
推进临床试验创新和数字健康转型,简化方法和流程,
开发新的信息学解决方案,提高效率,推动发现的实施,
改善健康和促进健康公平。在目标2中,我们将通过
扩大以能力为基础、以学习者为中心的解决方案的覆盖面,培训多样化、包容性、多学科的
CTS工作人员准备在快速变化的环境中满足所有社区的紧急医疗保健需求
环境在目标3中,我们将让当地社区成员和患者积极参与,
翻译团队,扩大服务不足的社区,包括农村人口的研究能力。
我们的目标是通过帮助这些社区实现以下目标,
CTS。在目标4中,我们将扩大国家和地区合作伙伴关系并加强CTS协作网络
在社区服务和教育的各个方面,注重分享创新方法和优先考虑多样性,
公平和包容,以改善人类健康和促进健康公平为目标。总的来说,
对CCaTS的持续投资将使我们能够继续应对卫生领域正在出现的挑战
关爱所有人,例如我们在COVID-19危机期间为社区提供支持。
项目摘要/摘要第289页
联系PD/PI:Lucchinetti,Claudia F.
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
VESNA D GAROVIC其他文献
VESNA D GAROVIC的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('VESNA D GAROVIC', 18)}}的其他基金
The KAPP-Sen Tissue Mapping Center Collaborative
KAPP-森组织绘图中心合作
- 批准号:
10701907 - 财政年份:2021
- 资助金额:
$ 781.85万 - 项目类别:
2021 Physiology in Focus: The Role of Sex Hormones, Genetics and Gender in Physiology & Medicine
2021 年生理学焦点:性激素、遗传学和性别在生理学中的作用
- 批准号:
10319292 - 财政年份:2021
- 资助金额:
$ 781.85万 - 项目类别:
The KAPP-Sen Tissue Mapping Center Collaborative
KAPP-森组织绘图中心合作
- 批准号:
10376627 - 财政年份:2021
- 资助金额:
$ 781.85万 - 项目类别:
Hypertensive pregnancy disorders and future coronary artery disease
妊娠高血压疾病和未来冠状动脉疾病
- 批准号:
10188609 - 财政年份:2018
- 资助金额:
$ 781.85万 - 项目类别:
Hypertensive pregnancy disorders and future coronary artery disease
妊娠高血压疾病和未来冠状动脉疾病
- 批准号:
10452767 - 财政年份:2018
- 资助金额:
$ 781.85万 - 项目类别:
Mayo Clinic Center for Clinical and Translational Science (CCaTS)
梅奥诊所临床和转化科学中心 (CCaTS)
- 批准号:
10674614 - 财政年份:2017
- 资助金额:
$ 781.85万 - 项目类别:
VEGF Signaling in Endothelial and Glomerular Epithelial Cells in Preeclampsia
先兆子痫中内皮细胞和肾小球上皮细胞中的 VEGF 信号转导
- 批准号:
8236793 - 财政年份:2008
- 资助金额:
$ 781.85万 - 项目类别:
VEGF Signaling in Endothelial and Glomerular Epithelial Cells in Preeclampsia
先兆子痫中内皮细胞和肾小球上皮细胞中的 VEGF 信号转导
- 批准号:
7846807 - 财政年份:2008
- 资助金额:
$ 781.85万 - 项目类别:
相似海外基金
Optimizing Health and Well-Being of Diverse Mothers with IDD and Their Infants During the Perinatal Period: A Virtual Advocate Tool for Data-Driven Supports
优化患有 IDD 的不同母亲及其婴儿在围产期的健康和福祉:用于数据驱动支持的虚拟倡导工具
- 批准号:
10760051 - 财政年份:2023
- 资助金额:
$ 781.85万 - 项目类别:
POSE: Phase II: Advocate Led Long-term Gameplan for Open OnDemand (ALL GOOD)
POSE:第二阶段:倡导者主导 Open OnDemand 的长期游戏计划(一切顺利)
- 批准号:
2303692 - 财政年份:2023
- 资助金额:
$ 781.85万 - 项目类别:
Standard Grant
Capitalising on our differences: A gathering to better understand and advocate for Early Career Health Researchers in Canada
利用我们的差异:更好地理解和倡导加拿大早期职业健康研究人员的聚会
- 批准号:
468168 - 财政年份:2022
- 资助金额:
$ 781.85万 - 项目类别:
Miscellaneous Programs
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10427960 - 财政年份:2022
- 资助金额:
$ 781.85万 - 项目类别:
Evaluating an ACEs-Targeting Advocate Model of a Substance Use Prevention Program
评估药物使用预防计划的针对 ACE 的倡导者模型
- 批准号:
10577074 - 财政年份:2022
- 资助金额:
$ 781.85万 - 项目类别:
The Art of Creation: Using Art-Based Knowledge Translation to Promote and Advocate for a Healthy Start to Life
创造的艺术:利用基于艺术的知识转化来促进和倡导健康的生命开端
- 批准号:
486588 - 财政年份:2022
- 资助金额:
$ 781.85万 - 项目类别:
Studentship Programs
When I am Old, I shall Wear Purple Nail Varnish: Utilising performance art to construct queer spaces that celebrate and advocate for ageing bodies
当我老了,我要涂紫色指甲油:利用行为艺术构建酷儿空间,庆祝和倡导衰老的身体
- 批准号:
2760091 - 财政年份:2022
- 资助金额:
$ 781.85万 - 项目类别:
Studentship
Addressing social adversity to improve outcomes among children undergoing liver transplant: the role for a health advocate on the transplant team
解决社会逆境以改善接受肝移植的儿童的预后:移植团队中健康倡导者的作用
- 批准号:
10621188 - 财政年份:2022
- 资助金额:
$ 781.85万 - 项目类别:
Techquity by FAITH!: A cluster randomized controlled trial to assess the efficacy of a community-informed, cardiovascular health promotion mobile hlth intervention with digital health advocate support
Techquity by FAITH!:一项整群随机对照试验,旨在评估社区知情、心血管健康促进移动 hlth 干预措施在数字健康倡导者支持下的效果
- 批准号:
10891016 - 财政年份:2021
- 资助金额:
$ 781.85万 - 项目类别:
CMV responses in autoantibody positive subjects advocate antiviral treatments for prevention of T1D
自身抗体阳性受试者的 CMV 反应主张抗病毒治疗以预防 T1D
- 批准号:
10230365 - 财政年份:2020
- 资助金额:
$ 781.85万 - 项目类别: